General Controls, Inspections Suffice For Reprocessed Class I Forceps - FDA
This article was originally published in The Gray Sheet
Executive Summary
Process validation compliance and monitoring of manufacturing provide reasonable assurances that reprocessed single-use non-electric biopsy forceps are sterile, FDA argues in denying a Boston Scientific citizen petition.
You may also be interested in...
Biopsy Forceps Review Request Prompts Category Change For Nine SUDs
Reprocessed single-use non-electric biopsy forceps will no longer be considered 510(k)-exempt devices, meaning that reprocessors will need to file premarket notification and validation data with FDA by July 30, 2004
Biopsy Forceps Review Request Prompts Category Change For Nine SUDs
Reprocessed single-use non-electric biopsy forceps will no longer be considered 510(k)-exempt devices, meaning that reprocessors will need to file premarket notification and validation data with FDA by July 30, 2004
Device Reuse: 510(k) Exemptions Terminated, Validation Guidance Awaited
FDA is retaining its 510(k)-exempt status for non-electric biopsy forceps, despite a further layer of scrutiny afforded by the Medical Device User Fee & Modernization Act